Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR4A2 | P43354 | 8/20 | 0.63 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.63 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.56 |
| ▸ | TUBB | P07437 | 2/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.56 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.56 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.56 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.56 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.56 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.56 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.56 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.56 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.56 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.56 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.56 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.56 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.56 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.52 |
| ▸ | DHPS | P49366 | 1/20 | 0.52 |
| ▸ | PIM1 | P11309 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30430559 | 1.00 | NR4A2 (0.63) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| Pyrimidine SCHEMBL28425509 | 0.90 | NR4A2 (0.52) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| Pyridine SCHEMBL28511928 | 0.90 | NR4A2 (0.52) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL2004209 | 0.86 | NR4A2 (0.49) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL27658621 | 0.82 | DHPS (0.52) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL6417970 | 0.82 | NUDT1 (0.57) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL7496719 | 0.82 | KDM4E (0.54) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL27788680 | 0.81 | TUBB4A (0.51) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL827588 | 0.80 | PBRM1 (0.59) | NR4A2CREBBPTUBB4ATUBBTUBA3C | |
| SCHEMBL29497247 | 0.80 | PBRM1 (0.59) | NR4A2CREBBPTUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 602 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118978469-B | Preparation process of (indole-4-yl) methanol | 安徽实特医药科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-118978469-A | Preparation process of (indole-4-yl) methanol | 安徽实特医药科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-112574093-B | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2022-10-04 | — | — | CN | claimed |
| CN-112574093-A | Novel green method for preparing 3-diaryl methyl substituted indole compound | 湖南理工学院 | 2021-03-30 | — | — | CN | claimed |
| EP-3080097-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | F. Hoffmann-La Roche AG (CH) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086635-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | F. HOFFMANN-LA ROCHE AG (CH) | 2015-06-18 | — | — | WO | claimed |
| CN-101942497-A | Method for quickly screening oxygenase microbes or oxygenase genes | CHENGDU INST BIOLOGY CAS | 2011-01-12 | — | — | CN | claimed |
| EP-1794163-A1 | METHOD OF PREPARING POLY(ADP-RIBOSE) POLYMERASES INHIBITORS | Pfizer, Inc. (US) | 2007-06-13 | — | — | EP | claimed |
| WO-2006033003-A1 | METHOD OF PREPARING POLY(ADP-RIBOSE) POLYMERASES INHIBITORS | PFIZER, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-6306203-B1 | FOR USE IN INK JET PRINTING, INCLUDING PIEZOELECTRIC INK JET PRINTING AND ACOUSTIC INK JET PRINTING | XEROX CORPORATION | 2001-10-23 | — | — | US | claimed |
| US-12577243-B2 | Monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-17 | — | — | US | disclosed |
| EP-3856178-B1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-11 | — | — | EP | disclosed |
| US-12570675-B2 | Boronic acid compounds | LG CHEM, LTD. (KR) | 2026-03-10 | — | — | US | disclosed |
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-20250388593-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2025-12-25 | — | — | US | disclosed |
| US-4435403-A | TRANQUILIZERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-03-06 | — | — | US | disclosed |
| US-4394514-A | Processes for preparing 4-substituted indoles | SMITHKLINE BECKMAN CORPORATION (US) | 1983-07-19 | — | — | US | disclosed |
| EP-0054507-A2 | 3-Substituted beta-carbolines, process for their production and compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-06-23 | — | — | EP | disclosed |
| US-3978066-A | Certain 4,6-dihydropyrrolotriazoline-quinoline derivatives | AYERST, MCKENNA AND HARRISON LTD. (CA) | 1976-08-31 | — | — | US | disclosed |
| US-3950343-A | PYRROLOISOQUINOLINE DERIVATIVES | AYERST, MCKENNA AND HARRISON LTD. (CA) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570675-B2 | Boronic acid compounds | PSMB6, PSMB3, PSMB2 | NR4A2 1564/4885CREBBP 3885/4885TUBB4A 3187/4885 |
| US-12577243-B2 | Monoacylglycerol lipase modulators | MGLL, LPL, FAAH | NR4A2 1245/4885CREBBP 2825/4885TUBB4A 3091/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | NR4A2 80/4885CREBBP 453/4885TUBB4A 952/4885 |
| US-20250388593-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | CRBN, CUL1, CBL | NR4A2 1071/4885CREBBP 722/4885TUBB4A 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.